Standout Papers

Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice 2000 2026 2008 2017 811
  1. Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice (2000)
    Debra A. Cockayne, Sara G. Hamilton et al. Nature
  2. P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study (2014)
    Rayid Abdulqawi, Rachel Dockry et al. The Lancet

Immediate Impact

37 by Nobel laureates 39 from Science/Nature 74 standout
Sub-graph 1 of 20

Citing Papers

Internal senses of the vagus nerve
2022 Standout
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials
2022 Standout
10 intermediate papers

Works of Anthony Ford being referenced

Gefapixant in two randomised dose-escalation studies in chronic cough
2020
The effect of gefapixant, a P2X3 antagonist, on cough reflex sensitivity: a randomised placebo-controlled study
2019
and 11 more

Author Peers

Author Last Decade Papers Cites
Anthony Ford 2670 2162 2359 2221 126 8.1k
Debra A. Cockayne 2069 1180 1318 1440 44 5.3k
Lori A. Birder 480 1413 5796 1608 203 8.8k
Y. Yiangou 749 1195 980 525 98 5.8k
Alison F. Brading 303 2303 3831 702 181 7.3k
Schuichi Koizumi 2412 2586 211 796 173 9.3k
Russ Chess‐Williams 169 1715 2369 934 191 6.3k
Anthony Kanai 195 1164 2984 900 133 5.6k
Jan de Vente 228 2766 949 851 159 6.7k
Iain P. Chessell 2621 1796 111 1030 121 7.7k
Paolo Santicioli 116 3053 2154 908 242 8.0k

All Works

Loading papers...

Rankless by CCL
2026